Prevalence and characteristics of breakthrough pain in cancer patients admitted to a hospice

Journal of Pain and Symptom Management

Volumn 20, Issue 2, 2000, Pages 87-92

  Zeppetella, Giovambattista ^a,b   O'Doherty, Catherine A ^a   Collins, Silke ^a  

^a Palliative Medicine   (United Kingdom)

^b ROYAL LONDON HOSPITAL   (United Kingdom)

Author keywords

Breakthrough pain; Cancer pain; Hospice

Indexed keywords

ANALGESIC AGENT; ANTICONVULSIVE AGENT; FENTANYL CITRATE; OPIATE;

ARTICLE; CANCER PAIN; CANCER PATIENT; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NEUROPATHY; PAIN ASSESSMENT; TERMINAL CARE; VISCERAL PAIN;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; HOSPICES; HUMANS; MALE; MIDDLE AGED; NEOPLASMS; PAIN; PROSPECTIVE STUDIES;

EID: 0033835177     PISSN: 08853924     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0885-3924(00)00161-5     Document Type: Article

References (17)

1. Takeda F. Results of field-testing in Japan of the WHO draft interim guidelines on relief of cancer pain. Pain Clin. 1:1986;83-89.
2. Ventafridda V., Tamburini M., Caraceni C., DeConno F., Naldi F. A validation study of the WHO method for cancer pain relief. Cancer. 59:1987;850-856.
3. Schug S.A., Zech D., Dorr U. Cancer pain management according to WHO analgesic guidelines. J Pain Symptom Manage. 5:1990;27-32.
4. Zech D.F.J., Grond S., Lynch J., Hertel D., Lehman K.A. Validation of World Health Organisation guidelines for cancer pain relief. A 10-year prospective study. Pain. 63:1995;65-76.
5. Hanks G., Portenoy R.K., MacDonald N., Forbes K. Difficult pain problems. Doyle D., Hanks G.W.C., MacDonald N. Oxford textbook of palliative medicine. 2nd ed:1998;454-477 Oxford University Press, Oxford.
6. Mercadante S., Maddaloni S., Roccella S., Salvaggio L. Predictive factors in advanced cancer pain treated only by analgesics. Pain. 50:1992;151-155.
7. Portenoy R.K., Hagen N.A. Breakthrough pain. definition, prevalence and characteristics Pain. 41:1990;273-281.
8. Portenoy R.K., Payne D., Jacobsen P. Breakthrough pain. characteristics and impact in patients with cancer pain Pain. 81:1999;129-134.
9. Petzke F., Radbruch L., Zech D., Loick G., Grond S. Temporal presentation of chronic cancer pain. transitory pains on admission to a multidisciplinary pain clinic J Pain Symptom Manage. 17:1999;391-401.
10. Fine P.G., Busch M.A. Characterisation of breakthrough pain by hospice patients and their caregivers. J Pain Symptom Manage. 16:1998;179-183.
11. De Conno F., Caraceni A. Manual of cancer pain. 1996;Kluwer Academic Publishers, London.
12. McQuay H.J., Carroll D., Jadad A.R., Wiffen P., Moore R.A. Anticonvulsant drugs for the management of pain. a systematic review Br Med J. 311:1995;1047-1052.
13. McQuay H.J., Tramer M., Nye B.A., Carroll D., Wiffen P., Moore R.A. A systematic review of antidepressants in neuropathic pain. Pain. 68:1996;217-227.
14. Morphine in cancer pain. modes of administration Br Med J. 312:1996;823-826.
15. Levy M.H. Pharmacologic treatment of cancer pain. N Engl J Med. 335:1996;1124-1132.
16. Working Party on Clinical Guidelines in Palliative Care. Guidelines for managing cancer pain in adults. National Council for Hospice and Specialist Palliative Care Services, 2nd ed. London 1998.
17. Portenoy R.K., Payne R., Coluzzi P., Raschko J.W., Lyss A., Busch M.A., Frigerio V., Loseth D.B., Nordbrock E., Rhiner M. Oral transmucosal fentanyl citrate (OTFC) for the treatment of breakthrough pain in cancer patients. a controlled dose titration study Pain. 79:1999;303-312.